DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Gamunex (Immune Globulin Intravenous Human) - Published Studies

 
 



Gamunex Related Published Studies

Well-designed clinical trials related to Gamunex (Immune Globulin Intravenous Human)

Evaluation of intravenous anthrax immune globulin for treatment of inhalation anthrax. [2013]

Treatment of neonatal sepsis with intravenous immune globulin. [2011.09.29]

Standard-dose intravenous anti-D immunoglobulin versus intravenous immunoglobulin in the treatment of newly diagnosed childhood primary immune thrombocytopenia. [2011.05]

Misleading hepatitis B test results due to intravenous immunoglobulin administration: implications for a clinical trial of rituximab in immune thrombocytopenia. [2010.12]

Safety and tolerability of immune globulin intravenous in chronic inflammatory demyelinating polyradiculoneuropathy. [2010.09]

Intravenous immunoglobulin therapy in autoimmune mucocutaneous blistering diseases: a review of the evidence for its efficacy and safety. [2010]

[Meta analysis of the effect of immunoglobulin infusion on neonatal isoimmune hemolytic disease caused by blood group incompatibility]. [Article in Chinese] [2010]

Safety and tolerability of immune globulin intravenous in chronic inflammatory demyelinating polyradiculoneuropathy. [2010]

A prospective, randomized, double-blinded, placebo-controlled study of human intravenous immunoglobulin for the acute management of presumptive primary immune-mediated thrombocytopenia in dogs. [2009.09]

Health-related quality-of-life improvements in CIDP with immune globulin IV 10%: the ICE Study. [2009.04.14]

Use of human immunoglobulin in addition to glucocorticoids for the initial treatment of dogs with immune-mediated hemolytic anemia. [2009.04]

Intravenous immune globulin versus intravenous anti-D immune globulin for the treatment of acute immune thrombocytopenic purpura. [2008.12]

Intravenous immunoglobulins in the treatment of immune neuropathies. [2008.10]

A single dose of anti-D immunoglobulin raises platelet count as efficiently as intravenous immunoglobulin in newly diagnosed immune thrombocytopenic purpura in Korean children. [2008.08]

Phase II, Randomized, Multicenter, Double-Blind, Placebo-Controlled Trial of a Polyclonal Anti-Staphylococcus aureus Capsular Polysaccharide Immune Globulin in Treatment of Staphylococcus aureus Bacteremia. [2007.12]

Antepartum Treatment Without Early Cordocentesis for Standard-Risk Alloimmune Thrombocytopenia: A Randomized Controlled Trial. [2007.08]

[Impact of intravenous nutrition on plasma free amino acid spectrum and immune function for patients with sepsis] [2007.05]

THROMBOCYTOPENIA ASSOCIATED WITH DENGUE HEMORRHAGIC FEVER RESPONDS TO INTRAVENOUS ADMINISTRATION OF ANTI-D (RH0-D) IMMUNE GLOBULIN. [2007.04]

Safety and tolerability of a novel chromatography-based intravenous immunoglobulin when administered at a high infusion rate in patients with immune thrombocytopenic purpura. [2007.03]

Is pertussis immune globulin efficacious for the treatment of hospitalized infants with pertussis? No answer yet. [2007.01]

Single dose of anti-D immune globulin at 75 microg/kg is as effective as intravenous immune globulin at rapidly raising the platelet count in newly diagnosed immune thrombocytopenic purpura in children. [2006.04]

Human botulism immune globulin for the treatment of infant botulism. [2006.02.02]

Parallel randomized trials of risk-based therapy for fetal alloimmune thrombocytopenia. [2006.01]

A randomized, double-blind, placebo-controlled pilot study of i.v. immune globulins in combination with i.v. methylprednisolone in the treatment of relapses in patients with MS. [2004.02]

Intravenous immunoglobulin plus interferon-alpha in autoimmune hepatitis C. [2004]

Low-dose versus high-dose immunoglobulin for primary treatment of acute immune thrombocytopenic purpura in children: results of a prospective, randomized single-center trial. [2003.10]

Comparison of the efficacy of IGIV-C, 10% (caprylate/chromatography) and IGIV-SD, 10% as replacement therapy in primary immune deficiency. A randomized double-blind trial. [2003.09]

Pharmacokinetics and tolerability of a new intravenous immunoglobulin preparation, IGIV-C, 10% (Gamunex, 10%). [2003.04]

Efficacy, tolerability, safety and pharmacokinetics of a nanofiltered intravenous immunoglobulin: studies in patients with immune thrombocytopenic purpura and primary immunodeficiencies. [2003.01]

Intravenous immunoglobulin or high-dose methylprednisolone, with or without oral prednisone, for adults with untreated severe autoimmune thrombocytopenic purpura: a randomised, multicentre trial. [2002.01.05]

High-dose intravenous immune globulin for stiff-person syndrome. [2001.12.27]

Intravenous immune globulins in patients with Guillain-Barre syndrome and contraindications to plasma exchange: 3 days versus 6 days. [2001.08]

Re-treatment for immune globulin-resistant Kawasaki disease: a comparative study of additional immune globulin and steroid pulse therapy. [2001.06]

Controlled trial of intravenous immune globulin in recent-onset dilated cardiomyopathy. [2001.05.08]

Intravenous immunoglobulin application following immunoadsorption: benefit or risk in patients with autoimmune diseases? [2001.05]

Cytomegalovirus immune globulin after liver transplantation: a cost-effectiveness analysis. [2000.02]

Use of human immunodeficiency virus (HIV) human hyperimmune immunoglobulin in HIV type 1-infected children (Pediatric AIDS clinical trials group protocol 273). [2000.02]

A multicenter, placebo-controlled pilot study of intravenous immune globulin treatment of antiphospholipid syndrome during pregnancy. The Pregnancy Loss Study Group. [2000.01]

Intravenous immunoglobulin for adults with autoimmune thrombocytopenic purpura: results of a randomized trial comparing 0.5 and 1 g/kg b.w. [1999.12]

Efficacy of zidovudine and human immunodeficiency virus (HIV) hyperimmune immunoglobulin for reducing perinatal HIV transmission from HIV-infected women with advanced disease: results of Pediatric AIDS Clinical Trials Group protocol 185. [1999.03]

High-dose intravenous immunoglobulin therapy in neonatal immune haemolytic jaundice. [1999.02]

Respiratory syncytial virus immune globulin for prophylaxis against respiratory syncytial virus disease in infants and children with congenital heart disease. The Cardiac Study Group. [1998.10]

A randomized trial of high dose polyvalent intravenous immunoglobulin (HDIgG) vs. Cytomegalovirus (CMV) hyperimmune IgG in allogeneic hemopoietic stem cell transplants (HSCT). [1998.02]

Respiratory syncytial virus immune globulin treatment of RSV lower respiratory tract infection in previously healthy children. [1997.12]

Randomized comparison of ganciclovir plus intravenous immune globulin (IVIG) with IVIG alone for prevention of primary cytomegalovirus disease in children receiving liver transplants. [1997.11]

Safety and efficacy of low-dose intravenous immune globulin (IVIG) treatment for infants and children with immune thrombocytopenic purpura. Low-Dose IVIG Study Group. [1997.05]

Respiratory syncytial virus (RSV) immune globulin intravenous therapy for RSV lower respiratory tract infection in infants and young children at high risk for severe RSV infections: Respiratory Syncytial Virus Immune Globulin Study Group. [1997.03]

Safety and pharmacokinetics of hyperimmune anti-human immunodeficiency virus (HIV) immunoglobulin administered to HIV-infected pregnant women and their newborns. Pediatric AIDS Clinical Trials Group Protocol 185 Pharmacokinetic Study Group. [1997.02]

No prevention of cytomegalovirus infection by anti-cytomegalovirus hyperimmune globulin in seronegative bone marrow transplant recipients. The Nordic BMT Group. [1997.02]

A controlled trial of intravenous immune globulin for the prevention of serious infections in adults with advanced human immunodeficiency virus infection. [1996.12.09]

Effects of intravenous immune globulin on the peripheral lymphocyte phenotypes in Kawasaki disease. [1996.10]

The use of intravenous immunoglobulin in recurrent pregnancy loss associated with combined alloimmune and autoimmune abnormalities. [1996.10]

Immunoprophylaxis against klebsiella and pseudomonas aeruginosa infections. The Federal Hyperimmune Immunoglobulin Trial Study Group. [1996.09]

Antenatal management of alloimmune thrombocytopenia with intravenous gamma-globulin: a randomized trial of the addition of low-dose steroid to intravenous gamma-globulin. [1996.05]

Intravenous immunoglobulin therapy for autoimmune diabetes mellitus. [1996.05]

Intravenous immune globulin in the treatment of intractable childhood epilepsy. [1996.05]

Intravenous immune globulin in multiple sclerosis: clinical and neuroradiological results and implications for possible mechanisms of action. [1996.05]

A controlled trial of long-term administration of intravenous immunoglobulin to prevent late infection and chronic graft-vs.-host disease after marrow transplantation: clinical outcome and effect on subsequent immune recovery. [1996.02]

Neonatal enterovirus infection: virology, serology, and effects of intravenous immune globulin. [1995.05]

Respiratory syncytial virus (RSV) infection in preterm infants and the protective effects of RSV immune globulin (RSVIG). Respiratory Syncytial Virus Immune Globulin Study Group. [1995.04]

A plasma exchange versus immune globulin infusion trial in chronic inflammatory demyelinating polyradiculoneuropathy. [1994.12]

Acute immune thrombocytopenic purpura: a comparative study of very high oral doses of methylprednisolone and intravenously administered immune globulin. [1994.12]

Intravenous immune globulin prophylaxis of late-onset sepsis in premature neonates. [1994.12]

A controlled trial of intravenous immune globulin for the prevention of serious bacterial infections in children receiving zidovudine for advanced human immunodeficiency virus infection. Pediatric AIDS Clinical Trials Group. [1994.11.03]

Passive hyperimmune plasma therapy in the treatment of acquired immunodeficiency syndrome: results of a 12-month multicenter double-blind controlled trial. The Passive Hyperimmune Therapy Study Group. [1994.10.01]

Randomised trial of intravenous immunoglobulin G, intravenous anti-D, and oral prednisone in childhood acute immune thrombocytopenic purpura. [1994.09.10]

Intravenous immune globulin in myasthenia gravis. [1994.07]

Intravenous immune globulin in the Guillain-Barre syndrome. [1994.07]

Intravenous immune globulin in recurrent abortion. [1994.07]

The use of intravenous immune globulin in multiple myeloma. [1994.07]

Intravenous immune globulin in chronic lymphocytic leukaemia. [1994.07]

Intravenous gammaglobulin has no advantages over oral corticosteroids as primary therapy for adults with immune thrombocytopenia: a prospective randomized clinical trial. [1994.07]

A controlled trial of intravenous immune globulin to reduce nosocomial infections in very-low-birth-weight infants. National Institute of Child Health and Human Development Neonatal Research Network. [1994.04.21]

A prospective randomized study of acyclovir versus ganciclovir plus human immune globulin prophylaxis of cytomegalovirus infection after solid organ transplantation. [1994.03.27]

Use of immune globulin to prevent symptomatic cytomegalovirus disease in transplant recipients--a meta-analysis. [1994.02]

A controlled trial of high-dose intravenous immune globulin infusions as treatment for dermatomyositis. [1993.12.30]

A prospective, randomized trial of high-dose intravenous immune globulin G therapy, oral prednisone therapy, and no therapy in childhood acute immune thrombocytopenic purpura. [1993.12]

Prophylactic administration of respiratory syncytial virus immune globulin to high-risk infants and young children. The Respiratory Syncytial Virus Immune Globulin Study Group. [1993.11.18]

Cytomegalovirus immune globulin prophylaxis in liver transplantation. A randomized, double-blind, placebo-controlled trial. [1993.11.15]

Treatment of adult chronic autoimmune thrombocytopenic purpura with repeated high-dose intravenous immunoglobulin. [1993.09.01]

Failure of high-dose oral acyclovir with or without immune globulin to prevent primary cytomegalovirus disease in recipients of solid organ transplants. [1993.09]

Controlled trial to evaluate protection of high-risk infants against respiratory syncytial virus disease by using standard intravenous immune globulin. [1993.08]

Comparison of group B streptococcal hyperimmune globulin and standard intravenously administered immune globulin in neonates. [1993.06]

Intravenous immune globulin for the prevention of infections in children with symptomatic human immunodeficiency virus infection. [1993.01]

Intravenous immune globulin therapy for early-onset sepsis in premature neonates. [1992.09]

Intravenous immune globulin for the prevention of nosocomial infection in low-birth-weight neonates. The Multicenter Group for the Study of Immune Globulin in Neonates. [1992.07.23]

High-dose intravenous immune globulin therapy for hyperbilirubinemia caused by Rh hemolytic disease. [1992.07]

Randomized trial of granulocyte transfusions versus intravenous immune globulin therapy for neonatal neutropenia and sepsis. [1992.02]

A randomized prospective trial of acyclovir and immune globulin prophylaxis in liver transplant recipients receiving OKT3 therapy. [1992.01]

[Experience with the use of immune intravenous immunoglobulin in symptomatic children with human immunodeficiency virus infection] [1991.12]

Efficacy and pharmacokinetics of intravenous immune globulin administration to high-risk neonates. [1991.11]

Treatment of septic thrombocytopenia with immune globulin. [1991.11]

Effect on neutrophil kinetics and serum opsonic capacity of intravenous administration of immune globulin to neonates with clinical signs of early-onset sepsis. [1991.04]

Well-designed clinical trials possibly related to Gamunex (Immune Globulin Intravenous Human)

Intravenous immunoglobulin treatment for secondary recurrent miscarriage: a randomised, double-blind, placebo-controlled trial. [2015]

Low-dose intravenous immunoglobulin treatment for complex regional pain syndrome (LIPS): study protocol for a randomized controlled trial. [2014]

Vigorimeter grip strength in CIDP: a responsive tool that rapidly measures the effect of IVIG--the ICE study. [2013]

The quantitative myasthenia gravis score: comparison with clinical, electrophysiological, and laboratory markers. [2012]

Intravenous immunoglobulin versus intravenous methylprednisolone for chronic inflammatory demyelinating polyradiculoneuropathy: a randomised controlled trial. [2012]

Use of intravenous immunoglobulin to treat chronic bilateral otomastoiditis in the setting of rituximab induced hypogammaglobulinemia. [2012]

Intravenous immunoglobulin therapy in adult patients with polymyositis/dermatomyositis: a systematic literature review. [2012]

Challenges of clinical trial design when there is lack of clinical equipoise: use of a response-conditional crossover design. [2012]

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017